Navigation Links
Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry
Date:5/22/2008

CHAPEL HILL, N.C., May 22 /PRNewswire/ -- Pharmaceutical and biotech companies increasingly are adopting a Risk-Based Approach (RBA) in their Quality Assurance (QA) functions. This benchmarking study will help R&D Quality Assurance executives tackle two current challenges:

-- Optimizing limited QA staff resources so that they have the most

effect

-- Optimizing services in regards to the FDA's Risk-Bases method for

selecting inspection sites

The study assesses the size of QA organizations relative to the size of the R&D functional areas they serve. Organizations are also evaluated on their implementation of Risk-Based Approach and its impact on QA workload and management.

For specific research topic included in the study download a complimentary sample of this research, "Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry," at http://www3.best-in-class.com/br128.htm .

"Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry" reflects the type of research Best Practices, LLC conducts for members of its Business Excellence Board ( http://www3.best-in-class.com/beb ), a research and advisory service for health care and pharmaceutical executives.

For information on other services by Best Practices, LLC and its Business Excellence Board, contact Cameron Tew at ctew@best-in-class.com or 919-403-0251, ext. 246.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
2. PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
3. New Study Recognizes Halogen Customer for Best Practices in Employee Performance and Talent Management
4. New Books on Best Practices in Biotechnology Business Development and Biotechnology Education
5. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
6. Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager
7. Vela Laboratories Receives the GMP Certificate for Its Analytical and Quality Control Laboratories
8. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
9. iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
10. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
11. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... COPENHAGEN, Denmark , March 22, 2017 /PRNewswire/ ... that utilizes its innovative TransCon technology to address ... announced financial results for the full year ended ... a significant year for our company as we ... become a leading, integrated rare disease company with ...
(Date:3/22/2017)... Mass. , March 22, 2017 Good ... that it has eclipsed the 130 million covered lives ... Blue Shield of Texas . With ... the Company continues to enjoy strong payor acceptance based ... its clinical programs and genetic counseling, its industry-leading customer ...
Breaking Biology Technology:
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
Breaking Biology News(10 mins):